Histotripsy of Pancreatic Cancer Liver Metastases: Early Outcomes and Imaging Findings.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40445073.
- Also identified by DOI 10.1002/wjs.12646.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with pancreatic ductal adenocarcinoma (PDAC) frequently present with liver metastases, which severely limit treatment options and prognosis. In other cancers, treatment of liver disease can improve outcomes and similar approaches are being explored in PDAC. Clinical data for locoregional control of pancreatic cancer liver metastases (PCLM) are limited, and histotripsy offers a new noninvasive tool for disease control. This study evaluates the preliminary safety, efficacy, and imaging findings of histotripsy in patients with PCLM.
Medical subject headings
- Pancreatic Neoplasms
- Liver Neoplasms
- Carcinoma, Pancreatic Ductal
- High-Intensity Focused Ultrasound Ablation